Explore more publications!

Palau Science & Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palau Science & Technology Journal.

Press releases published on November 13, 2025

Data Storage Corporation Postpones 2025 Third Quarter Business Update Conference Call
Digi Power X Achieves Positive Net Earnings for Q3 2025 and Reports Strong Balance Sheet to Support 2026 AI Infrastructure Development Plan
Aptose Reports Third Quarter 2025 Results
Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results after Dosing with EP-104GI
Geotab Partners with Swinburne University of Technology to Advance Connected Transportation Research in Australia
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update
FLYR Expands Two-Year Presence and Major Investment in Saudi Arabia with Regional Headquarters
Intermap Reports Third Quarter 2025 Results
Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
Astrotech Reports First Quarter of Fiscal Year 2026 Financial Results
SAIC Announces Organizational Changes Intended to Simplify Structure, Sharpen Focus and Deliver Sustainable Long-Term Growth and Shareholder Value Creation
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
NANOBIOTIX annonce les avancées de sa plateforme de nanoprimer Curadigm avec une mise à jour des plans de développement pour son pipeline interne et des collaborations externes
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
Innventure Reports Third Quarter 2025 Results
Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
Fennec Pharmaceuticals Announces Proposed Offering of Common Shares

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions